NCT05637437Completed
Peer-Supported Diabetes Self-Care Intervention to Improve Health Related Quality of Life (HRQoL) and Diabetes Management
Peer-Supported Diabetes Self-Care Intervention to Improve Health-Related Quality of Life (HRQoL) and Diabetes Management in the Elderly With Type 2 Diabetes (T2DM): A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 7 Aug 2026
Brief summary (registry, in English)
Diabetes mellitus is the ninth leading cause of mortality worldwide. Diabetes is a chronic condition with a major impact on the life and well-being of individuals, families, and societies globally. The three main types of diabetes are type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM); approximately 90% of the total cases accounts for T2DM. T2DM is characterized by chronic hyperglycaemia and affects 9.5% of adults aged 20-99 years. The highly burdensome condition is predominantly prevalent in elderly population and distresses 19.3% of elderly aged 65-99 years. Elderly with diabetes have poor Health related Quality of Life (HRQoL) in comparison with their peers of similar age from the general populations. The determinants of poor HRQoL in elderly with T2DM diabetes population are - poor glycemic control, long duration of diabetes, multiple co-morbidities, depression, high body mass index (BMI), poor self-management practices, higher diabetes related distress, low social support and increased social isolation. Diabetes Self-management Education and Support (DSME/S) is a critical element of care to improve the overall condition of diabetic patients. Self-care does play a critical role in elderly diabetes management. The goal of the current clinical trial is to develop and assess the effectiveness of peer supported diabetes self-care intervention in improving the HRQoL in elderly with type 2 diabetes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 12 Nov 2022
- Start date
- 14 Jul 2025
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- Universiti Putra Malaysia
- Diseases
- Type 2 diabetes
- NCT number
- NCT05637437
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 14 Jul 2025 to the primary completion date, 28 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Debilitating medical or related condition (e.g. end-stage cancer, severe mental illness)
Other
- Physical inability to provide self-care
Who the study is looking for
- Age must be 60 years or more
- Diagnosed with T2DM by physician minimum for more than 1 year
- The ability to communicate in Malay or English language properly
- The ability to perform daily activities independently
- No major complications (e.g.- dementia, blind, deaf)
- Planned to continue receiving care at this clinic for next 6 months
- Participated at the usual education session
- Access to a smart phone with internet
Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universiti Putra Malaysia (UPM) Coordinator of this site? Confirm its status | Serdang | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.